Vishnu Lekraj

Latest articles

11d
Crain's Chicago Business
CVS-Aetna merger leaves Walgreens on different pathdoesn't require a tit-for-tat response. "CVS has pursued an entirely different
Crain's Chicago Business / Posted 11 days ago
doesn't require a tit-for-tat response. "CVS has pursued an entirely different strategy," says Morningstar analyst Vishnu Lekraj. "Walgreens wants to continue to be a retailer, (whereas) CVS is moving down the path of becoming an... Read more
470 related articles
12d
Boston Herald
CVS inks $69B deal to buy Aetnaor visits that don’t need to be at physician’s office for visits to CVS, that c
Boston Herald / Posted 12 days ago
or visits that don’t need to be at physician’s office for visits to CVS, that could be a lot cheaper,” Morningstar analyst Vishnu Lekraj told the Herald. “That would ultimately mean better pricing for the insurance products overall and less... Read more
470 related articles
24d
Morningstar
25 Overstuffed Stocksmanaged-care organizations is uncertain. However, even with a more difficult op
Morningstar / Posted 24 days ago
managed-care organizations is uncertain. However, even with a more difficult operating environment, senior equity analyst Vishnu Lekraj thinks Aetna possesses competitive advantages that should allow it to produce outsize economic profits over an... Read more

In this news